Evidence map›Paper›PMID 37949932›Full record

ArticleScientific reports2023

The association of copeptin with metabolic risk markers is modified by region of origin.

Anna Franzén, Miriam Pikkemaat, Olle Melander, Louise Bennet, Sofia Enhörning

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anna FranzénDepartment of Clinical Sciences in Malmö, Lund University, Clinical Research Center 91:12, Jan Waldenströms gata 35, 21428, Malmö, Sweden. anna.franzen@med.lu.se.
Miriam PikkemaatDepartment of Clinical Sciences in Malmö, Lund University, Clinical Research Center 91:12, Jan Waldenströms gata 35, 21428, Malmö, Sweden.
Olle MelanderDepartment of Clinical Sciences in Malmö, Lund University, Clinical Research Center 91:12, Jan Waldenströms gata 35, 21428, Malmö, Sweden.
Louise BennetDepartment of Clinical Sciences in Malmö, Lund University, Clinical Research Center 91:12, Jan Waldenströms gata 35, 21428, Malmö, Sweden.
Sofia EnhörningDepartment of Clinical Sciences in Malmö, Lund University, Clinical Research Center 91:12, Jan Waldenströms gata 35, 21428, Malmö, Sweden.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iraqi born immigrants in Sweden have higher prevalence of metabolic diseases compared to native Swedes. Copeptin, a marker for vasopressin, is associated with increased risk of metabolic disease. In this cross-sectional population study based on the MEDIM cohort we investigated differences in copeptin levels between Iraqi and Swedish born individuals and if the association between copeptin and cardiometabolic risk markers differed by region of origin. We included 1109 Iraqi and 613 Swedish born participants (58% men, mean age 47 years). The Swedish participants had a higher concentration of copeptin compared to the Iraqi born group after age and sex adjustment (p < 0.001). This difference existed only among male individuals with the highest copeptin concentrations, i.e. belonging to copeptin quartile 4 (median (25th; 75th percentile) 20.07 (15.27;33.28) pmol/L for the Swedish born versus 15.57 (13.91;19.00) pmol/L for the Iraqi born, p < 0.001). We found a significant interaction between copeptin (continuous ln-transformed) and being born in Iraq regarding the association with plasma triglycerides (P

Indexed as

GlycopeptidesCross-Sectional StudiesFemaleHumansMaleMetabolic DiseasesMiddle AgedSwedencopeptinsGlycopeptides

Identifiers

PMID37949932
PMCPMC10638355
OpenAlexW4388563928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.